ArticleJournal of translational medicine2022

A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management.

Melissa Bradbury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.